Rachna Murthy
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Prevention and Management of Complications With a Hyaluronic Acid-Calcium Hydroxyapatite Hybrid Injectable.
Journal: Clinical, cosmetic and investigational dermatology
Published: November 22, 2024
Comment on: Epimax-related ocular surface toxicity (EROST): the Glasgow experience.
Journal: Eye (London, England)
Published: July 22, 2023
TFOS Lifestyle: Impact of cosmetics on the ocular surface.
Journal: The ocular surface
Published: April 04, 2023
Thyrotropin Receptor Autoantibody Assessment in Thyroid Eye Disease: Does the Assay Type Matter?
Journal: Korean journal of ophthalmology : KJO
Published: October 13, 2022
Inhibition of Fibrotic Contraction by Sirolimus (Rapamycin) in an Ex Vivo Model of Thyroid Eye Disease.
Journal: Ophthalmic plastic and reconstructive surgery
Published: November 25, 2020
Improving aseptic injection standards in aesthetic clinical practice.
Journal: Dermatologic therapy
Published: August 27, 2020
Teprotumumab for Active Thyroid Eye Disease.
Journal: The New England journal of medicine
Published: May 14, 2020
Update on the clinical assessment and management of thyroid eye disease.
Journal: Current opinion in ophthalmology
Published: July 18, 2019
Periocular hyaluronic acid fillers: applications, implications, complications.
Journal: Current opinion in ophthalmology
Published: July 02, 2019
Sirolimus (rapamycin) for the targeted treatment of the fibrotic sequelae of Graves' orbitopathy.
Journal: Eye (London, England)
Published: January 07, 2019
Last Updated: 09/26/2026